Xlife Sciences AG (XLS) — Capital Reinvestment Ratio

Latest as of December 2023: 0.24x

Xlife Sciences AG (XLS) has a Capital Reinvestment Ratio of 0.24x as of December 2023, meaning it reinvests 0% of its operating cash flow (CHF171.78K) in capital expenditures (CHF41.08K). Check Xlife Sciences AG tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

CHF171.78K
CHF

Capital Expenditures

CHF41.08K
CHF

Data as of

Dec 2023
Most recent filing

Xlife Sciences AG Capital Reinvestment Ratio (2023–2023)

This chart tracks Xlife Sciences AG's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see XLS cash generation efficiency.

Annual Capital Reinvestment Ratio for Xlife Sciences AG (2023–2023)

Year-by-year Capital Reinvestment Ratio for Xlife Sciences AG from 2023 to 2023. See how much free cash does Xlife Sciences AG generate to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CHF) Capital Expenditures YoY Change
2023 0.24x CHF171.78K CHF41.08K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow